Antiluteolytic effects of bovine trophoblast protein-1. 1989

W W Thatcher, and P J Hansen, and T S Gross, and S D Helmer, and C Plante, and F W Bazer
Department of Dairy Science, University of Florida, Gainesville 32611-0701.

Bovine conceptuses exert an antiluteolytic (anti-PGF-2 alpha) effect on the uterus by decreasing the secretion of PGF that results in maintenance of the CL. Basal and oxytocin-stimulated secretion rates of PGF from perifused endometrium are lower at Day 17 of pregnancy than at Day 17 of the oestrous cycle, probably because of increased amounts of an intracellular, endometrial PG-synthesis inhibitor which is present in the 100,000 g cytosolic supernatant, is proteinaceous, and acts in a noncompetitive manner with respect to arachidonic acid. The antiluteolytic signal in bovine conceptus secretory proteins (bCSP) is bovine trophoblast protein-1 (bTP-1), a group of 7 isomers of N-linked glycoproteins in two size classes (22,000 high-mannose and 24,000 complex types) that are related immunologically to ovine trophoblast protein-1 (oTP-1). Incubation of endometrial explants of Day-17 cyclic cows with bCSP and bTP-1 induced PG-synthesis inhibitor activity and reduced PGF secretion. Intrauterine infusion of bTP-1 from Days 15.5 to 21 extended the interoestrous interval from 19.5 to 26.0 days. Intrauterine infusion of interferon-alpha I 1 through the cervix from Day 15.5 to 21 extended the interoestrous interval from 22.8 to 26.8 days. Platelet-activating factor (PAF) and interferon-alpha I 1 alter PG secretion of endometrial explants (PAF decreases PGF and increases PGE-2; interferon-alpha I 1 does not alter PGF and increases PGE-2 secretion) but neither induces activity of the endometrial PG-synthesis inhibitor. In conclusion, bovine conceptuses exert a paracrine effect through the secretion of bTP-1 to induce an endometrial intracellular inhibitor of PGF synthesis.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007370 Interferon Type I Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA). Interferons Type I,Type I Interferon,Type I Interferons,Interferon, Type I,Interferons, Type I
D008186 Luteolytic Agents Chemical compounds that cause LUTEOLYSIS or degeneration of the CORPUS LUTEUM. Luteolytic Agent,Luteolytic Effect,Luteolytic Effects,Agent, Luteolytic,Agents, Luteolytic,Effect, Luteolytic,Effects, Luteolytic
D010972 Platelet Activating Factor A phospholipid derivative formed by PLATELETS; BASOPHILS; NEUTROPHILS; MONOCYTES; and MACROPHAGES. It is a potent platelet aggregating agent and inducer of systemic anaphylactic symptoms, including HYPOTENSION; THROMBOCYTOPENIA; NEUTROPENIA; and BRONCHOCONSTRICTION. AGEPC,Acetyl Glyceryl Ether Phosphorylcholine,PAF-Acether,Phosphorylcholine, Acetyl Glyceryl Ether,1-Alkyl-2-acetyl-sn-glycerophosphocholine,Platelet Aggregating Factor,Platelet Aggregation Enhancing Factor,Platelet-Activating Substance,Thrombocyte Aggregating Activity,1 Alkyl 2 acetyl sn glycerophosphocholine,Aggregating Factor, Platelet,Factor, Platelet Activating,PAF Acether,Platelet Activating Substance
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011257 Pregnancy Proteins Proteins produced by organs of the mother or the PLACENTA during PREGNANCY. These proteins may be pregnancy-specific (present only during pregnancy) or pregnancy-associated (present during pregnancy or under other conditions such as hormone therapy or certain malignancies.) Placental Proteins,Proteins, Placental,Proteins, Pregnancy
D011270 Pregnancy, Animal The process of bearing developing young (EMBRYOS or FETUSES) in utero in non-human mammals, beginning from FERTILIZATION to BIRTH. Animal Pregnancies,Animal Pregnancy,Pregnancies, Animal
D011460 Prostaglandins F (9 alpha,11 alpha,13E,15S)-9,11,15-Trihydroxyprost-13-en-1-oic acid (PGF(1 alpha)); (5Z,9 alpha,11,alpha,13E,15S)-9,11,15-trihydroxyprosta-5,13-dien-1-oic acid (PGF(2 alpha)); (5Z,9 alpha,11 alpha,13E,15S,17Z)-9,11,15-trihydroxyprosta-5,13,17-trien-1-oic acid (PGF(3 alpha)). A family of prostaglandins that includes three of the six naturally occurring prostaglandins. All naturally occurring PGF have an alpha configuration at the 9-carbon position. They stimulate uterine and bronchial smooth muscle and are often used as oxytocics. PGF
D001755 Blastocyst A post-MORULA preimplantation mammalian embryo that develops from a 32-cell stage into a fluid-filled hollow ball of over a hundred cells. A blastocyst has two distinctive tissues. The outer layer of trophoblasts gives rise to extra-embryonic tissues. The inner cell mass gives rise to the embryonic disc and eventual embryo proper. Embryo, Preimplantation,Blastocysts,Embryos, Preimplantation,Preimplantation Embryo,Preimplantation Embryos
D002417 Cattle Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor. Beef Cow,Bos grunniens,Bos indicus,Bos indicus Cattle,Bos taurus,Cow,Cow, Domestic,Dairy Cow,Holstein Cow,Indicine Cattle,Taurine Cattle,Taurus Cattle,Yak,Zebu,Beef Cows,Bos indicus Cattles,Cattle, Bos indicus,Cattle, Indicine,Cattle, Taurine,Cattle, Taurus,Cattles, Bos indicus,Cattles, Indicine,Cattles, Taurine,Cattles, Taurus,Cow, Beef,Cow, Dairy,Cow, Holstein,Cows,Dairy Cows,Domestic Cow,Domestic Cows,Indicine Cattles,Taurine Cattles,Taurus Cattles,Yaks,Zebus
D003340 Corpus Luteum Maintenance Process of maintaining the functions of CORPORA LUTEA, specifically PROGESTERONE production which is regulated primarily by pituitary LUTEINIZING HORMONE in cycling females, and by PLACENTAL HORMONES in pregnant females. The ability to maintain luteal functions is important in PREGNANCY MAINTENANCE. Luteal Maintenance,Maintenance of Luteal Function,Luteal Function Maintenance,Luteum Maintenance, Corpus,Luteum Maintenances, Corpus

Related Publications

W W Thatcher, and P J Hansen, and T S Gross, and S D Helmer, and C Plante, and F W Bazer
May 1988, The Journal of endocrinology,
W W Thatcher, and P J Hansen, and T S Gross, and S D Helmer, and C Plante, and F W Bazer
November 1987, The Journal of endocrinology,
W W Thatcher, and P J Hansen, and T S Gross, and S D Helmer, and C Plante, and F W Bazer
October 1990, Molecular endocrinology (Baltimore, Md.),
W W Thatcher, and P J Hansen, and T S Gross, and S D Helmer, and C Plante, and F W Bazer
February 1989, Biology of reproduction,
W W Thatcher, and P J Hansen, and T S Gross, and S D Helmer, and C Plante, and F W Bazer
May 1996, Annals of the New York Academy of Sciences,
W W Thatcher, and P J Hansen, and T S Gross, and S D Helmer, and C Plante, and F W Bazer
January 1989, Molecular endocrinology (Baltimore, Md.),
W W Thatcher, and P J Hansen, and T S Gross, and S D Helmer, and C Plante, and F W Bazer
September 1988, Biology of reproduction,
W W Thatcher, and P J Hansen, and T S Gross, and S D Helmer, and C Plante, and F W Bazer
January 1992, Reproduction, fertility, and development,
W W Thatcher, and P J Hansen, and T S Gross, and S D Helmer, and C Plante, and F W Bazer
January 1991, Journal of reproduction and fertility. Supplement,
W W Thatcher, and P J Hansen, and T S Gross, and S D Helmer, and C Plante, and F W Bazer
December 2009, Prostaglandins & other lipid mediators,
Copied contents to your clipboard!